Nuclear medicine in times of COVID-19: How radiopharmaceuticals could help to 
fight the current and future pandemics

Neumaier, Felix; Zlatopolskiy, Boris D.; Neumaier, Bernd

doi:10.3390/pharmaceutics12121247

Local TagsRelease HistoryDetailsSummary

Nuclear medicine in times of COVID-19: How radiopharmaceuticals could help to fight the current and future pandemics

Neumaier, F., Zlatopolskiy, B. D., & Neumaier, B. (2020). Nuclear medicine in times of COVID-19: How radiopharmaceuticals could help to fight the current and future pandemics. Pharmaceutics, 12(12): 1247. doi:10.3390/pharmaceutics12121247.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/21.11116/0000-0007-B7DA-5 Version Permalink: https://hdl.handle.net/21.11116/0000-0007-B7DB-4

Genre: Journal Article

Files

show Files

Locators

show

Creators

show

hide

Creators:
Neumaier, Felix, Author
Zlatopolskiy, Boris D.¹, Author
Neumaier, Bernd¹, Author

Affiliations:
1Radiochemistry, Scientific Services and Development, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149672

Content

show

Details

show

hide

Language(s): eng - English

Dates: Date issued: 2020

Publication Status: Issued

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: Peer

Identifiers: DOI: 10.3390/pharmaceutics12121247

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: Pharmaceutics

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: Basel : MDPI

Pages: - Volume / Issue: 12 (12) Sequence Number: 1247 Start / End Page: - Identifier: ISSN: 1999-4923
CoNE: https://pure.mpg.de/cone/journals/resource/1999-4923